Zjazd Polskiego Towarzystwa Biochemicznego

 on-line journal

No.
 Presenting person
 Title
P5.1 Karol Jelonek Polymorphism of DNA repair genes as a cancer risk factor; comparison between head and neck squamous cell carcinoma and colon cancer
P5.2 Urszula Lewandowska The role of WWOX in normal and pathological cell metabolism
P5.3 Justyna K. Broniarczyk Decreased level of TSG101 expression in epithelial cells at different stages of cervical cancer development is presumably not regulated by epigenetic modifications.
P5.4 Katarzyna A. Szołtysek Expression of the YEATS protein family in human cancer tissues.
P5.5 Małgorzata Presler Reduced expression of the ZAC mRNA in bladder cancer
P5.6 Anna Krześlak Expression and subcellular distribution of Akt1 in thyroid lesions
P5.7 Jarosław Paluszczak Modulation of the activity of DNA methyltransferases by plant phenolic compounds
P5.8 Ludmiła Węglarz The influence of phytic acid on NFκB expression in human colon cancer cells
P5.9 Beata Parfiniewicz Expression of genes of tumor necrosis factor -α and its receptors in colon cancer Caco-2 cells treated with inositol hexaphosphate
P5.10 Małgorzata Kapral Expression of matrix metalloproteinase 2 and matrix metalloproteinase 9 in laryngeal squamous cell carcinoma
P5.11 Małgorzata Wolańska Matrix metalloproteinases and their inhibitors of human leiomyoma in various stages of tumor growth.
P5.12 Monika Mach The changes of actin cytoskeleton triggered by cofilin and gelsolin are correlated with high metastatic potential of human colon adenocarcinoma cells
P5.13 Agata Radwańska Vinculin distribution accompanying to lumican-induced actin reorganization in human melanoma A375 cells
P5.14 Jadwiga Snarska Activity of α-fucosidase in serum and urine of smoking patients with colon adenocarcinoma.
P5.15 Jan Stec Effect of benzo(α)pyrene and aflatoxin B1 on sheep lymphocytes infected with bovine leukemia virus
P5.16 Monika A. Pietrowska Analyses of lymphocyte radiosensitivity in vitro for identification of predictive biomarkers of early response to radiotherapy in head and neck cancer patients
P5.17 Robert Nowak The sensitivity of immortalized hybrid endothelial-cancer cells EA.hy926 to UVC radiation in comparison with human promyelocytic leukaemia HL60 cells
P5.18 Ewa Chodurek The thermochemolysis of melanins isolated from melanoma malignum
P5.19 Magdalena Łuczak Application of 2-D electrophoresis and MALDI-TOF mass spectrometry for proteomic analysis of human acute myeloid leukemia cells
P5.20 Łukasz Marczak MALDI-TOF mass spectrometry analysis of blood serum proteins for the preparation for breast cancer biomarker discovery
P5.21 Leszek Szmigiero The effect of introduction of a formamidino group to the molecule of doxorubicin on its biological properties
P5.22 Dorota Kostrzewa-Nowak The role of bioreductive activation of idarubicin in the cytotoxic activity against leukaemia HL60 sensitive cell line and its multidrug resistant sublines
P5.23 Agnieszka A. Maruszewska The effect of antitumour agents, vincristine and doxorubicin, on non-enzymatic and enzymatic NADPH oxidation stimulated by pyridinium salts
P5.24 Kamila Siedlecka Resveratrol and apoptosis in MOLT-4 human leukemia cells
P5.25 Iwona Mitrus Use of conjugate of paclitaxel with PGA in melanoma tumour therapy in mice
P5.26 Ryszard Smolarczyk Combination of anticancer peptide (CAMEL) with immunotherapy in B16(F10) murine melanoma tumor therapy
P5.27 Andrzej Smagur New chimeric protein ABRaA-VEGF121 is selectively cytotoxic towards cells overexpressing VEGFR2 (KDR) and inhibits growth of primary tumors.
© 1998-2024 pielaszek research, all rights reserved Powered by the Conference Engine